Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingParkland Community MRI Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentParkland Community Health PlanPolicy N/A

    MRI Imaging for Suspected Placenta Accreta

    Customize your policy alerts

    Sign up for all parklandcommunityhealthplan policy alerts

    Know when parklandcommunityhealthplan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Establishes medical necessity and prior authorization requirements for pelvic MRI used to evaluate suspected placenta accreta spectrum for PCHP STAR and CHIP members in Texas.

    Policy Summary
    PayerParkland Community Health Plan
    PolicyMRI Imaging for Suspected Placenta Accreta
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOctober 16, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit the required clinical and imaging documentation for pelvic MRI in PCHP STAR and CHIP members.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    5Clinical PAS risk-factor categories
    5Situations supporting adjunctive MRI
    6Authorization documentation elements
    3Applicable pelvic MRI codes
    5

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Not medically necessary scenarios

    Medical Necessity and Coverage Criteria

    Initial medical necessity criteria

    Pelvic MRI may be considered medically necessary when all of the following are met.

    Medical necessity for MRI of the pelvis

    • Clinical risk factor for PAS

      • The member has a prior cesarean delivery.
      • The member has placenta previa.
      • The member has a history of prior uterine surgery or curettage.
      • The member has Asherman syndrome.
      • The member has a low-lying placenta.
    • Indeterminate or incomplete ultrasound or clinical assessment

      • Ultrasound findings are equivocal or inconclusive for placenta accreta spectrum.
      • The placental-myometrial interface cannot be adequately visualized.
      • A posterior placenta previa causes technically limited ultrasound visualization.
      • Clinical risk factors are discordant with ultrasound findings.
      • Assessment of invasion depth is needed in suspected placenta percreta, including evaluation of parametrial or bladder involvement.
    • Expected management impact

      • MRI results are expected to influence delivery planning.
      • MRI results are expected to influence surgical planning.
      • MRI results are expected to determine multidisciplinary care needs.
      • MRI results are expected to support selection of a delivery facility with appropriate maternal-fetal medicine and surgical capabilities.

    MRI is not medically necessary for routine screening of asymptomatic pregnancies, initial evaluation without a prior targeted obstetric ultrasound, low-risk pregnancy with normal ultrasound findings and no clinical concern for placenta accreta spectrum, repeat imaging without a change in clinical status, or requests that do not document how MRI results will affect management.

    MRI should not be used as the sole diagnostic test for placenta accreta spectrum. It is intended as an adjunct to appropriate obstetric evaluation rather than a replacement for diagnostic assessment.

    MRI is not medically necessary when there is no documented clinical indication beyond routine screening, when targeted obstetric ultrasound has not been performed for the initial evaluation, when ultrasound findings are normal in a low-risk pregnancy without clinical concern for placenta accreta spectrum, when repeat imaging is requested without a change in clinical status, or when the expected impact on management is not documented.

    Applicable Pelvic MRI Codes

    Covered CPT CodesCPTCovered
    72195MRI - pelvis, when applicable
    72196MRI - pelvis, when applicable
    72197MRI - pelvis, when applicable

    Authorization and Documentation Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required before pelvic MRI for suspected placenta accreta spectrum (PAS) for PCHP STAR and CHIP members.

    • Applies to utilization management reviews, prior authorization determinations, and claim adjudication determinations.
    Documentation Required

    Required Authorization Documentation

    Authorization requests must include clinical records and supporting diagnostic documentation sufficient to establish the need for MRI and explain how the results will guide care.

    • Obstetric ultrasound report
    • Maternal-fetal medicine consultation notes, if available
    • Documentation of PAS risk factors
    • Estimated gestational age

    Clinical Background

    Placenta accreta spectrum describes abnormal adherence or invasion of placental villi into the myometrium and includes placenta accreta, increta, and percreta. MRI may provide additional assessment when targeted obstetric ultrasound is equivocal, incomplete, technically limited, or discordant with the clinical risk, particularly when the extent of invasion must be evaluated. Findings may support delivery and surgical planning, multidisciplinary care decisions, or selection of a facility with appropriate maternal-fetal medicine and surgical capabilities.

    Placenta Accreta Spectrum Terminology

    Placenta Accreta Spectrum (PAS)
    ConditionPlacenta Accreta Spectrum (PAS)
    DefinitionAbnormal adherence or invasion of placental villi into the myometrium.
    Included conditionsPlacenta accreta, placenta increta, and placenta percreta.
    Placenta Accreta
    ConditionPlacenta accreta
    DefinitionSuperficial attachment of the placenta to the myometrium.
    Spectrum classificationPlacenta accreta is one of the conditions included in placenta accreta spectrum.

    When Adjunctive MRI Is Covered

    Diagnosis and assessment of suspected placenta accreta spectrum

    Adjunctive pelvic MRI may be considered for diagnosis and assessment of suspected placenta accreta spectrum when all of the following are met.

    Suspected PAS MRI indication

    • Significant PAS risk factor

      • The member has a prior cesarean delivery.
      • The member has placenta previa.
      • The member has a history of prior uterine surgery or curettage.
      • The member has Asherman syndrome.

    Repeat Imaging Limitations

    MRI Frequency Limit
    ModalityMRI
    Frequency ruleRepeat MRI is not medically necessary without evidence of a change in clinical status.
    Applicable regionPelvis

    Prior Authorization Status

    Prior Authorization

    Authorize each medically necessary pelvic MRI

    Prior authorization is required for pelvic MRI for PCHP STAR and CHIP members. No frequency threshold is stated, but repeat MRI is not medically necessary without evidence of a change in clinical status.

    • Applicable pelvic MRI CPT codes include 72195, 72196, and 72197.

    Contrast Use During Pregnancy

    Billing Rule

    Apply pregnancy contrast safeguards

    Gadolinium contrast is generally not recommended during pregnancy unless the expected benefit clearly outweighs the potential fetal risks. MRI should use protocols appropriate for pregnancy and fetal safety.

    • Document the benefit-risk consideration when gadolinium is used during pregnancy.
    • Do not use MRI as the sole diagnostic test for placenta accreta spectrum.

    Non-Covered MRI Uses

    The following uses are not covered as medically necessary: routine MRI screening of asymptomatic pregnancies; MRI as the initial evaluation without a prior targeted obstetric ultrasound; MRI for a low-risk pregnancy with normal ultrasound findings and no clinical concern for placenta accreta spectrum; repeat MRI without evidence of a change in clinical status; requests that do not document how MRI results will affect management; and MRI used as the sole diagnostic test for placenta accreta spectrum.

    Policy Summary
    PayerParkland Community Health Plan
    PolicyMRI Imaging for Suspected Placenta Accreta
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOctober 16, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit the required clinical and imaging documentation for pelvic MRI in PCHP STAR and CHIP members.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaApplicable Pelvic MRI CodesAuthorization and Documentation RequirementsClinical BackgroundPlacenta Accreta Spectrum TerminologyWhen Adjunctive MRI Is CoveredRepeat Imaging LimitationsPrior Authorization StatusContrast Use During PregnancyNon-Covered MRI Uses
  1. Clinical rationale explaining why MRI is needed beyond ultrasound findings
  2. Documentation describing how MRI results will affect treatment or delivery planning
  3. Denial Risk

    Non-Covered Utilization Scenarios

    MRI is not medically necessary for suspected PAS in the following situations and may be denied.

    • Routine screening of asymptomatic pregnancies
    • Initial evaluation without prior targeted obstetric ultrasound
    • Low-risk pregnancy with normal ultrasound findings and no clinical concern for PAS
    • Repeat MRI without evidence of a change in clinical status
    • Requests lacking documentation demonstrating how MRI results will impact management
    Placenta Increta
    ConditionPlacenta increta
    DefinitionInvasion of the placenta into the myometrium.
    Spectrum classificationPlacenta increta is one of the conditions included in placenta accreta spectrum.
    Placenta Percreta
    ConditionPlacenta percreta
    DefinitionExtension of the placenta through the uterine serosa.
    Potential involvementThe extension may reach adjacent organs.
    The member has a low-lying placenta.
  4. Unresolved or technically limited ultrasound or clinical assessment

    • Ultrasound findings are equivocal or inconclusive for placenta accreta spectrum.
    • The placental-myometrial interface cannot be adequately visualized.
    • A posterior placenta previa causes technically limited ultrasound visualization.
    • Clinical risk factors are discordant with ultrasound findings.
    • Assessment of invasion depth is needed in suspected placenta percreta, including evaluation of parametrial or bladder involvement.
  5. Expected impact on clinical management

    • MRI results are expected to influence delivery planning.
    • MRI results are expected to influence surgical planning.
    • MRI results are expected to determine multidisciplinary care needs.
    • MRI results are expected to support selection of a delivery facility with appropriate maternal-fetal medicine and surgical capabilities.